(Q62785019)
Statements
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients (English)
Luigi Marcheselli
Francesco Angrilli
Daniele Vallisa
Maura Brugiatelli
Italian Lymphoma Study Group